Fermentation process optimization of recombinant Saccharomyces cerevisiae for the production of human interferon-alpha2a

Appl Biochem Biotechnol. 2003 Dec;111(3):129-38. doi: 10.1385/abab:111:3:129.

Abstract

The effects of different culture conditions on the expression level of human interferon-alpha2a (IFN-alpha2a) by using recombinant yeast were investigated in a 2.6-L jar fermentor. Appropriate supplement of glucose and the maintenance of residual glucose at a low level resulted in the reduction of ethanol formation and enhancement of the bioactivity of IFN-alpha2a to 4.9 x 106 from 3.1 x 10(6) IU/mL. When adenine was added evenly for 10-20 h of fermentation into the basal culture medium at a speed of 2 microg/mL of medium/h, OD600 was greatly increased to 24, and the protein increased to 276 mg/L. The content of ethanol generated was also reduced tremendously during the process, and as a result, 1.3 x 10(7) IU/mL of biologic activity was achieved. In the expression phase, pH had an important impact on expression level, which should be controlled at 5.5.

MeSH terms

  • Adenine / pharmacology
  • Culture Media
  • Ethanol / analysis
  • Ethanol / metabolism
  • Fermentation
  • Gene Expression Regulation / drug effects
  • Glucose / pharmacology
  • Humans
  • Hydrogen-Ion Concentration
  • Interferon alpha-2
  • Interferon-alpha / biosynthesis*
  • Interferon-alpha / genetics
  • Peptones / pharmacology
  • Plasmids / genetics
  • Recombinant Proteins / genetics
  • Saccharomyces cerevisiae / genetics*
  • Saccharomyces cerevisiae / growth & development
  • Saccharomyces cerevisiae / metabolism
  • Time Factors

Substances

  • Culture Media
  • Interferon alpha-2
  • Interferon-alpha
  • Peptones
  • Recombinant Proteins
  • Ethanol
  • Glucose
  • Adenine